Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - Julien Guiot, MD PhD

University

Julien Guiot, MD PhD

ULiège, CHU
" We are facing a COVID-19 infection pandemic. This pathogenic virus is a source of pulmonary complications greatly aggravating the prognosis of our patients. Today, both the pathophysiological mechanisms involved and the predictive markers of the severity of the disease remain unclear. It therefore seems urgent to be able to identify prognostic and diagnostic markers for our patients on the one hand. In this context, several paths that can quickly be explored appear to us to be critical. This is why we are planning the evaluation of the neutrophilic activation pathway by studying the Exosomes and circulating nucleosomes containing neutrophilic activation markers. This tool would make it possible to identify people at risk of clinical deterioration but also to approach the pathophysiological mechanisms involved. "
Funding: Fonds Léon Fredericq
Publication References: 1Danthi P. Viruses and the Diversity of Cell death Annu. Rev. Virol. (2016) 3:533–53 2 Wang Y et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. (2009) 184(2):205–213 3 Kalaaji M. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis (2007) 71(7):665-672 4 Ashar H et al. The Role of Extracellular Histones in Influenza Virus Pathogenesis (2018) Jan;188(1):135-148 5 Marcos V. et al. CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Nat Med (2010) 16:1018–23 6 Hoeksema M. et al. Histones as mediators of host defense, inflammation and thrombosis. Future Microbiol (2016) 11:441–53. 7 Zeerlander S. Elevated nucleosome levels in systemic inflammation and sepsis. Critical Care Medicine (2003) 31(7):1947-51 8 Letendre JA. Determining prognosis in canine sepsis by bedside measurement of cell-free DNA and nucleosomes. J Vet Emerg Crit Care (San Antonio). (2018) Nov;28(6):503-511 9 Letendre JA. Concentrations of Plasma Nucleosomes but Not Cell-Free DNA Are Prognostic in Dogs Following Trauma. Frontiers in Veterinary Science. (2018) Jul;5: 180 10 Geiger S. Nucleosomes as a new prognostic marker in early cerebral stroke. J Neurol (2007) 254:617–623 11 Borissoff JI. Elevated Levels of Circulating DNA and Chromatin Are Independently Associated With Severe Coronary Atherosclerosis and a Prothrombotic State. Arterioscler Thromb Vasc Biol. (2013) 33:2032 2040 12 Holdenrieder S. et al. Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med. 2001 Jul;39(7):596-605 13 Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol 2018 18:134–147 Guiot, J., Struman, I., Louis, E., Louis, R., Malaise, M., Njock MS. Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic Targets. J Clin Med. 2019 Aug 29;8(9) Guiot*, J., Makon-Sébastien*, N., Henket, M., Nivelles, O., Thiry, M., Dequiedt, F., Corhay, J.-L., Louis, R., & Struman, I. Sputum exosomal microRNAs as promising biomarkers for Idiopathic Pulmonary Fibrosis. Thorax 2018 Sep 22 - Guiot, J., Struman, I., Chavez, V., Henket, M., Herzog, M., Scoubeau, K., Hardat, N., Bondue, B., Corhay, J.-L., Moermans, C., & Louis, R. (2017, Augustus). Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis. Clinical Epigenetics, 9:84.
Contact: J.Guiot@chuliege.be

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11

info@COVID19-WB.be

Brussels & Wallonia against COVID19

AcceptRead more about cookies

Disclaimer - Terms and conditions of use


The purpose of the provisions below is to define the conditions under which the F.R.S.-FNRS gives you access to this website www.COVID19-WB.be.

1. Acceptance of the general conditions of use

The F.R.S.-FNRS gives you access to the www.COVID19-WB.be website and the information contained therein, you accept these conditions. The F.R.S.-FNRS may modify them at any time.

2. Use of the website

The content of this website is provided to you for general information purposes only. The content of this website may only be used in connection with the services offered on the website and for your personal use. This website may not be used as a basis for any evaluation of the F.R.S.-FNRS and may in no way bind or be opposable to the F.R.S.-FNRS. Nothing on the website can be considered as an offer to purchase or provide services or to conclude a contract.

The user undertakes to use the website in compliance with the laws and legal and/or contractual notices. The user may not use it in any way that would prejudice the interests of the F.R.S.-FNRS and/or its partners.

3. Guarantees and limitations of liability for the use of the website

In general, the F.R.S.-FNRS cannot, under any circumstances, be held liable for direct or indirect damage, or for any other damage of any nature whatsoever, resulting from the use of this website or from the impossibility of using it for any reason whatsoever, whether or not this liability is contractual, tortious or quasi-delictual, or whether it is based on no-fault liability or otherwise, and this even if the F.R.S.-FNRS is not liable for any damage resulting from the use of this website or from the impossibility of using it for any reason whatsoever, whether or not this liability is contractual, tortious or quasi-delictual, or whether it is based on no-fault liability or otherwise, and this even if the F.R.S.-FNRS is not liable for any damage resulting from the use of this website. FNRS would have been advised of the possibility of such damages.

3.1 Information

The information on this site is the exclusive responsibility of its authors. The F.R.S.-FNRS uses all reasonable means to publish on this website information which, to its knowledge, is up to date. However, it does not guarantee the adequacy, accuracy or exhaustiveness of such information nor does it guarantee that the website will always be complete and up to date in all respects. The information contained on this website may contain inaccuracies in content, technical inaccuracies or typing errors. This information is provided for information purposes only and is subject to periodic changes. The F.R.S.-FNRS may be required to make improvements and/or changes to this website at any time and without notice.

The use of this website, and consequently the information obtained, or elements downloaded when using the service, is the sole responsibility of the user. The F.R.S.-FNRS declines all responsibility for any damage that may result from the use of the information on this website.

The user also acknowledges that he or she shall be solely responsible for any damage to his or her computer system or any loss of data resulting from the downloading of any content.

3.2. Hypertext links

This website contains hypertext links to other sites as well as references to other sources of information, which are provided for your information only. The F.R.S.-FNRS does not control these sites and the information contained therein and therefore cannot offer any guarantee as to the quality and/or exhaustive nature of this information.

The F.R.S.-FNRS declines all responsibility for any unsuitable, illegitimate or illegal content present on the hyperlinks as well as for any damage that may result from consulting them.

3.3. Acts of Internet users

The F.R.S.-FNRS shall in no way be held responsible for the actions of Internet users.

4. Intellectual property rights

The trademarks on the site (www.COVID19-WB.be) may not be used in connection with any product or service other than those of the F.R.S.-FNRS, in any way that is likely to create confusion or in any way that would depreciate or discredit the F.R.S.-FNRS.

Unless explicitly authorized to do so, the user may not, under any circumstances, copy, reproduce, translate, represent, modify, transmit, publish, adapt, distribute, broadcast, license, transfer, sell, on any medium whatsoever, by any means whatsoever, or exploit in any way whatsoever, all or part of this website without the prior written authorization of the F.R.S.-FNRS. Any infringement may result in civil and criminal prosecution.

AcceptRead more about cookies